NEW DELHI : The Subject Expert Committee (SEC)on Covid-19 of he Central Drugs Standard Control organisation(CDSCO) lend its nod to conduct clinical trials of vaccine children ages 2 - 18 years.
The permission comes for trial phases 2 and 3 of Bharat Biotech’s Covaxin shots. 525 volunteering kids will be subject to trials at various hospitals including AIIMS(Delhi), AIIMS(Patna) and Meditrina Hospital, Nagpur. Hyderabad-based Bharat Biotech had developed the vaccine with assistance from ICMR.
The decision came over Bharat Biotechs application to CDSCO seeking to conduct clinical trials to evaluate the safety, reactogenicity and immunogenocity of Covaxin shots in children.
